Aquilo Capital, L.P., 10% Owner at Spero Therapeutics, Inc. (SPRO), sold 174,100 shares at $13.77 ($2.5M) on 2020-11-06, disclosed to the SEC on 2020-11-06.
Open-market sale of $2.5M SPRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.26 | 72,500 | $1.0M | 42.1% |
| 2 | $13.98 | 96,600 | $1.4M | 55.0% |
| 3 | $13.77 | 5,000 | $69K | 2.8% |
| Total | $14.09 avg | 174,100 | $2.5M | 100% |
| Filing → |
| SPRO | BUY | 2022-03-02 | $855K | — | Filing → |
| SPRO | BUY | 2022-01-26 | $17K | — | Filing → |
| SPRO | BUY | 2021-11-02 | $2.6M | — | Filing → |